TASK-1 and TASK-3 channels modulate pressure overload-induced cardiac remodeling and dysfunction

Wei Duan1, Jonné Hicks1, Michael A Makara2

  • 1Department of Medicine, Duke University Medical Center, Durham, North Carolina.

Insights

Loss of TASK-1 channels protects against cardiac dysfunction and hypertrophy by enhancing AKT signaling and metabolic function. TASK-1 and TASK-3 channels play significant roles in pressure overload-induced heart disease.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Ion Channel Function

Background:

  • Tandem pore domain acid-sensitive K+ (TASK) channels are implicated in cardiac function, but their specific roles in cardiac pathophysiology remain unclear.
  • TASK channel expression is altered in human cardiac hypertrophy and heart failure, suggesting a link to disease development.

Purpose of the Study:

  • To investigate the roles of TASK-1 and TASK-3 channels in the pathogenesis of cardiac dysfunction.
  • To elucidate the molecular mechanisms underlying the effects of TASK channel loss of function on cardiac response to stress.

Main Methods:

  • Analysis of human cardiac tissue for TASK-1 gene expression in hypertrophy and heart failure.
  • Utilized global knockout mouse models (TASK-1 KO and TASK-3 KO) to study pressure overload-induced cardiomyopathy.
  • Assessed cardiac function, hypertrophy, AKT phosphorylation, and PGC-1α expression in response to pressure overload.

Main Results:

  • TASK-1 gene expression is reduced in human cardiac hypertrophy and heart failure.
  • TASK-1 KO mice exhibited reduced cardiac hypertrophy and preserved function under pressure overload compared to wild-type mice.
  • TASK-1 loss of function enhanced AKT phosphorylation and PGC-1α expression, improving cardiac energetics and fatty acid oxidation.

Conclusions:

  • TASK-1 channel loss of function confers cardioprotection against pressure overload by promoting hypertrophic signaling and metabolic adaptation.
  • TASK-1 and TASK-3 channels significantly influence the development of cardiac hypertrophy and dysfunction in response to injury.
  • Targeting TASK-1 channels may represent a therapeutic strategy for treating cardiac dysfunction.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
603
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
307
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.3K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
842
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.2K